Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy
Publication
, Conference
Gandara, DR; Mack, PC; Omori, A; Grimminger, P; Joshi, M-BM; Harpole, DH; Danenberg, KD
Published in: JOURNAL OF THORACIC ONCOLOGY
September 1, 2009
Duke Scholars
Published In
JOURNAL OF THORACIC ONCOLOGY
ISSN
1556-0864
Publication Date
September 1, 2009
Volume
4
Issue
9
Start / End Page
S401 / S402
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gandara, D. R., Mack, P. C., Omori, A., Grimminger, P., Joshi, M.-B., Harpole, D. H., & Danenberg, K. D. (2009). Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. In JOURNAL OF THORACIC ONCOLOGY (Vol. 4, pp. S401–S402). LIPPINCOTT WILLIAMS & WILKINS.
Gandara, David R., Philip C. Mack, Akiko Omori, Peter Grimminger, Mary-Beth M. Joshi, David H. Harpole, and Kathleen D. Danenberg. “Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy.” In JOURNAL OF THORACIC ONCOLOGY, 4:S401–2. LIPPINCOTT WILLIAMS & WILKINS, 2009.
Gandara DR, Mack PC, Omori A, Grimminger P, Joshi M-BM, Harpole DH, et al. Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. In: JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S401–2.
Gandara, David R., et al. “Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy.” JOURNAL OF THORACIC ONCOLOGY, vol. 4, no. 9, LIPPINCOTT WILLIAMS & WILKINS, 2009, pp. S401–02.
Gandara DR, Mack PC, Omori A, Grimminger P, Joshi M-BM, Harpole DH, Danenberg KD. Ribonucleotide reductase (RRM1) expression in non-small cell lung cancer (NSCLC): implications for personalizing gemcitabine-based therapy. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2009. p. S401–S402.
Published In
JOURNAL OF THORACIC ONCOLOGY
ISSN
1556-0864
Publication Date
September 1, 2009
Volume
4
Issue
9
Start / End Page
S401 / S402
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology